StreetInsider.com News Articles

Form 4 ACHIEVE LIFE SCIENCES, For: Aug 19 Filed by: Stewart Richard Alistair

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961776.html

Form 4 ACHIEVE LIFE SCIENCES, For: Aug 19 Filed by: Stewart Richard Alistair

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961776.html

Form 144 ACHIEVE LIFE SCIENCES, Filed by: Stewart Richard Alistair

Wed, 19 Aug 2026 09:16:00 -0400

si-local-file:///var/storage/secattach/20260819/26948103.html

Form 144 ACHIEVE LIFE SCIENCES, Filed by: Stewart Richard Alistair

Wed, 19 Aug 2026 09:16:00 -0400

si-local-file:///var/storage/secattach/20260819/26948103.html

Form SCHEDULE 13G ACHIEVE LIFE SCIENCES, Filed by: Logos Global Management LP

Mon, 17 Aug 2026 19:43:00 -0400

si-local-file:///var/storage/secattach/20260817/26939290.html

Form SCHEDULE 13G ACHIEVE LIFE SCIENCES, Filed by: Logos Global Management LP

Mon, 17 Aug 2026 19:43:00 -0400

si-local-file:///var/storage/secattach/20260817/26939290.html

Form 8-K ACHIEVE LIFE SCIENCES, For: Aug 14

Fri, 14 Aug 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260814/26930590.html

Form 8-K ACHIEVE LIFE SCIENCES, For: Aug 14

Fri, 14 Aug 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260814/26930590.html

Form 424B5 ACHIEVE LIFE SCIENCES,

Fri, 14 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260814/26930149.html

Form 424B5 ACHIEVE LIFE SCIENCES,

Fri, 14 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260814/26930149.html

Form SCHEDULE 13G ACHIEVE LIFE SCIENCES, Filed by: Janus Henderson Group Ltd.

Thu, 13 Aug 2026 12:31:00 -0400

si-local-file:///var/storage/secattach/20260813/26919130.html

Form SCHEDULE 13G ACHIEVE LIFE SCIENCES, Filed by: Janus Henderson Group Ltd.

Thu, 13 Aug 2026 12:31:00 -0400

si-local-file:///var/storage/secattach/20260813/26919130.html

Morgan Stanley Starts Achieve Life Sciences (ACHV) at Overweight

Thu, 13 Aug 2026 02:43:31 -0400

Morgan Stanley analyst Maxwell Skor initiates coverage on Achieve Life Sciences (NASDAQ: ACHV) with a Overweight rating and a price target of $13.00.

The analyst comments: “We initiate coverage of Achieve Life Sciences (ACHV) with an Overweight rating and a $13 price target. Smoking continues to be the leading preventable cause of death both globally and in the United States. Cytisinicline is believed to aid in treating nicotine addiction for smoking and ecigarette cessation by interacting with nicotine receptors in the brain, reducing the severity of nicotine craving symptoms, and reducing the reward and satisfaction associated with nicotine products. Cytisinicline is

Morgan Stanley Starts Achieve Life Sciences (ACHV) at Overweight

Thu, 13 Aug 2026 02:43:31 -0400

Morgan Stanley analyst Maxwell Skor initiates coverage on Achieve Life Sciences (NASDAQ: ACHV) with a Overweight rating and a price target of $13.00.

H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences (ACHV)

Wed, 12 Aug 2026 07:27:50 -0400

H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating and $12.00 price target on Achieve Life Sciences (NASDAQ: ACHV).

The analyst commented: "ACHV’s 2Q26 results reinforce our view that the key risks have shifted away from financing and cytisinicline’s clinical approvability and toward execution of the planned 4Q26 NDA resubmission and subsequent commercial launch. The most important financial metric this quarter, in our view, is the $187.3M of cash, cash equivalents and marketable securities at June 30. With the balance sheet now strengthened, the FDA having identified no clinical efficacy or clinical safety deficiencies in its June CRL, and ACHV continuing

Form 10-Q ACHIEVE LIFE SCIENCES, For: Jun 30

Tue, 11 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260811/26905768.html

Form 10-Q ACHIEVE LIFE SCIENCES, For: Jun 30

Tue, 11 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260811/26905768.html

Form 8-K ACHIEVE LIFE SCIENCES, For: Aug 11

Tue, 11 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260811/26905546.html

Form 8-K ACHIEVE LIFE SCIENCES, For: Aug 11

Tue, 11 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260811/26905546.html

Achieve Life Sciences (ACHV) Misses Q2 EPS by 64c

Tue, 11 Aug 2026 09:33:09 -0400

Achieve Life Sciences (NASDAQ: ACHV) reported Q2 EPS of ($0.80), $0.64 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates